Randomized phase III trial of neoadjuvant chemotherapy in head and neck cancer: 10-year follow-up.
about
Interventions for the treatment of oral cavity and oropharyngeal cancer: chemotherapyInterventions for the treatment of oral and oropharyngeal cancers: surgical treatmentThe role of systemic treatment before, during, and after definitive treatmentSequential induction chemotherapy followed by radical chemo-radiation in the treatment of locoregionally advanced head-and-neck cancer.Proton and phosphorous MR spectroscopy in squamous cell carcinomas of the head and neckA non-randomized comparison of gemcitabine-based chemoradiation with or without induction chemotherapy for locally advanced squamous cell carcinoma of the head and neck.Phase I trial of radiotherapy concurrent with twice-weekly gemcitabine for head and neck cancer: translation from preclinical investigations aiming to improve the therapeutic ratio.A single centre experience with sequential and concomitant chemoradiotherapy in locally advanced stage IV tonsillar cancerA Phase II Study of Docetaxel, Cisplatin and 5- Fluorouracil (TPF) In Patients with Locally Advanced Head and Neck Carcinomas.Systemic therapy strategies for head-neck carcinomas: Current statusInduction chemotherapy in the management of squamous cell carcinoma of the head and neck.Induction chemotherapy in patients with resectable head and neck squamous cell carcinoma: a meta-analysis.Radiotherapy for the management of locally advanced squamous cell carcinoma of the head and neck.Diffusion-weighted magnetic resonance imaging for predicting and detecting early response to chemoradiation therapy of squamous cell carcinomas of the head and neck.Outcomes of Induction Chemotherapy for Head and Neck Cancer Patients: A Combined Study of Two National Cohorts in Taiwan.Diffusion-weighted imaging in head and neck cancers.Integrating systemic agents into multimodality treatment of locally advanced head and neck cancer.Clinical efficacy of neoadjuvant chemotherapy with platinum-based regimen for patients with locoregionally advanced head and neck squamous cell carcinoma: an evidence-based meta-analysis.Update on role of chemotherapy in head and neck squamous cell cancer.Pharmacotherapy of head and neck cancer.Potential Role of PET/MRI for Imaging Metastatic Lymph Nodes in Head and Neck Cancer.Efficacy and safety of early G-CSF administration in patients with head and neck cancer treated by docetaxel-cisplatin and 5-fluorouracil (DCF protocol): a retrospective study.National patterns of care and predictors of neoadjuvant and concurrent chemotherapy use with definitive radiotherapy in the treatment of patients with oropharyngeal squamous cell carcinoma.Comparison of postoperative complications in advanced head and neck cancer patients receiving neoadjuvant chemotherapy followed by surgery versus surgery alone.Efficacy and safety of dose-modified docetaxel plus cisplatin-based induction chemotherapy in Asian patients with locally advanced head and neck cancer.Low-cost outpatient chemotherapy regimen of cisplatin, 5-fluorouracil and leucovorin for advanced head and neck and esophageal carcinomas.p16INK4a Status and Response to Induction Low-Dose Fractionated Radiation in Advanced Head and Neck Cancer.Concomitant chemoradiotherapy versus induction docetaxel, cisplatin and 5 fluorouracil (TPF) followed by concomitant chemoradiotherapy in locally advanced head and neck cancer: a phase II randomized study.Strategies for non-resectable head and neck cancer.Sequential therapy for the locally advanced larynx and hypopharynx cancer subgroup in TAX 324: survival, surgery, and organ preservation.Prediction of response to chemoradiation therapy in squamous cell carcinomas of the head and neck using dynamic contrast-enhanced MR imaging.Functional organ preservation after chemoradiotherapy in elderly patients with loco-regionally advanced head and neck squamous cell carcinoma.Gemcitabine-based induction chemotherapy and concurrent with radiation in advanced head and neck cancer.Phase 2 trial of oxaliplatin and pemetrexed as an induction regimen in locally advanced head and neck cancer.Effectiveness of incorporating cetuximab into docetaxel/cisplatin/fluorouracil induction chemotherapy and chemoradiotherapy for inoperable squamous cell carcinoma of the oral cavity: A phase II study.The Italian Collaborative Group sets a standard for the treatment of locally advanced head and neck cancer.A Phase I Clinical Trial of AZD1775 in Combination With Neoadjuvant Weekly Docetaxel and Cisplatin Before Definitive Therapy in Head and Neck Squamous Cell Carcinoma.Induction docetaxel and S-1 followed by concomitant radiotherapy with low-dose daily cisplatin in locally advanced head and neck carcinoma.
P2860
Q24235245-8B5491AC-3E58-4301-89FA-A97A720A33AAQ24242951-0065814B-6A0F-4590-8BF5-026BE6127A63Q26859285-DD956647-CEF8-4C7A-96EC-E65F720F96AAQ33380006-AD496A95-9A29-4257-9305-822534118FCDQ33483238-2E929EC9-45C1-452C-AA49-C3C807D7BE76Q33491298-5AF8B6DD-F5BE-4132-A3CB-F6415C644F18Q34369298-FFBBE271-889E-4F3F-BDE8-ED56444EEC5EQ34498577-120A1942-ED3F-4824-8A2F-9048E8441638Q36022400-A1FE8A9D-CE2D-4F41-BC08-3A85ECE4D61AQ36529843-DB955A9C-46D7-474F-AEA9-74167151C326Q36613979-9674A3AE-49DF-48AF-9F2A-59F41A304A8DQ36697794-AC99F17D-661C-4205-BB8F-E88D151157D0Q37093034-8728C2BA-C516-4B30-B541-AADF7A1279ADQ37170947-997569B9-95A7-4E80-92FC-65B0DC1CC9E8Q37206229-E8E14662-A3A1-42F2-AB8E-0EEED8081344Q37469917-250EF526-20E3-428E-B4A2-A97BABFC71A7Q37799933-07A7E28F-666E-4D85-A4A2-6F8D0EFB37F8Q37930854-C53B6952-DB86-47A9-A680-633772491DE4Q38038836-37B9BFCC-6C47-42D7-BE69-C2583F564FBAQ38619293-F9C3399A-C6E1-49B8-AF00-9DCEA84D9B79Q38830809-08949E07-A205-401B-BCDF-24008BCD1EE0Q39193669-82F53F05-3244-42E4-8AA8-2333270761FBQ39370399-22BB5CBA-AE8E-47DC-9B96-1DCEADA19CC7Q40060938-15FA3756-B6EB-43B2-946E-1E8156847E9DQ40310924-2519E126-0CD6-4313-9C26-19A75417FC04Q40421238-32406193-FC21-4F13-92A2-F7BFA040274DQ41382440-AD0C8796-045E-46D5-9289-59DE4DFFD0A1Q43209150-E859F632-F953-4D76-89E2-610C0887E42DQ43978706-BB1E0C54-45F6-4954-9B31-D17275658A44Q44536370-F3DE4B24-BE4C-4EE0-94DC-DB997CEBAF26Q44783059-409EEC78-8428-4B1A-923C-E13A5CB6E55AQ44792291-BEA14079-6D55-4185-BBFE-EF94A3113B76Q44808667-A1B58BE5-E947-4A68-A98E-272C08E0B560Q45221883-053CA483-8AA6-4FCD-B45B-ACC6FEBAB078Q47926809-DA90CE18-BB67-4BF9-B136-4D88E82BC8C7Q50088438-D99D1714-B800-4A5E-8ECC-A12EB7C6089CQ51740619-52D34D3A-F6CF-4F7F-97B6-3D11D99B64F4Q52884293-4F808B43-BE9B-4EB6-AB50-EF0B24AFF914
P2860
Randomized phase III trial of neoadjuvant chemotherapy in head and neck cancer: 10-year follow-up.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Randomized phase III trial of ...... eck cancer: 10-year follow-up.
@en
Randomized phase III trial of ...... eck cancer: 10-year follow-up.
@nl
type
label
Randomized phase III trial of ...... eck cancer: 10-year follow-up.
@en
Randomized phase III trial of ...... eck cancer: 10-year follow-up.
@nl
prefLabel
Randomized phase III trial of ...... eck cancer: 10-year follow-up.
@en
Randomized phase III trial of ...... eck cancer: 10-year follow-up.
@nl
P2093
P356
P1476
Randomized phase III trial of ...... neck cancer: 10-year follow-up
@en
P2093
Adriano Paccagnella
Alessandro Bordin
Alessandro Gava
Antonella Fede
Antonio Jirillo
Antonio Orlando
Carlo Alberto Mione
Carlo Marchiori
Fanny Boldrin
Francesco Lunghi
P304
P356
10.1093/JNCI/DJH306
P407
P577
2004-11-01T00:00:00Z